IRCT20221110056463N2
Completed
Phase 4
Comparison of the Effectiveness of 10% Oxybutynin Topical Gel and 20% Aluminum Chloride in Patients with Primary Hyperhidrosis: a Randomized Double-Blind Controlled Trial
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Kerman University of Medical Sciences
- Enrollment
- 30
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Primary Excessive Sweating with a Score of 3 or Higher on the Hyperhidrosis Disease Severity Scale (HDSS), at Least in the last 6 Months
- •No Treatment during 6 Months before Entering the Study with Iontophoresis, Botulinum Toxin Injection
- •no Performance of Sympathectomy
Exclusion Criteria
- •Pregnant and Lactating Women
- •People who have Secondary Excessive Sweating due to an External Factor
- •People with Active Skin Disease such as: Psoriasis, Eczema, Seborrhea and Skin Infection, Glaucoma, Urinary Retention, Myasthenia Gravis, Sjögren's Syndrome or Sicca Syndrome
- •History of Allergy to Aluminum Salts
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 4
A randomised trial comparing the effectiveness of oxybutynin and mirabegron in reducing symptoms of frequency and urgency in patients with benign prostatic hyperplasia receiving medical treatment with tamsulosin.Health Condition 1: N401- Benign prostatic hyperplasia withlower urinary tract symptomsCTRI/2019/10/021513JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION RESEARCH96
Completed
Phase 3
Assessing the effectiveness of oxybutynin and phenazopyridine and celecoxib in reducing complications in the treatment of bladder tumors.Malignant neoplasm of bladder.Malignant neoplasm of bladderIRCT20171225038070N1Iran University of Medical Sciences120
Not yet recruiting
Phase 3
To study the role of Oxybutinin in infants affected with posterior urethral valveHealth Condition 1: Q642- Congenital posterior urethral valvesCTRI/2023/08/056095Josy Thomas
Completed
Not Applicable
A comparative study between treatment with oxybutynin and botulinum toxin type A in patients with neurogenic detrusor overactivityISRCTN56769820Dr Henrique Santillo Rehabilitation Center (Brazil)68
Not yet recruiting
Not Applicable
Treatment of primary palmar hyperhidrosisSkin and Connective Tissue DiseasesPACTR202006915898923Mansoura university faculty of medicine80